DE2946275C2 - - Google Patents

Info

Publication number
DE2946275C2
DE2946275C2 DE2946275A DE2946275A DE2946275C2 DE 2946275 C2 DE2946275 C2 DE 2946275C2 DE 2946275 A DE2946275 A DE 2946275A DE 2946275 A DE2946275 A DE 2946275A DE 2946275 C2 DE2946275 C2 DE 2946275C2
Authority
DE
Germany
Prior art keywords
cells
interferon
human
substance
priming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2946275A
Other languages
German (de)
English (en)
Other versions
DE2946275A1 (de
Inventor
Peter Dr. Swetly
Gerhard Dr. Bodo
Guenther Wien At Adolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Priority to DE19792946275 priority Critical patent/DE2946275A1/de
Priority to AT0506880A priority patent/AT374828B/de
Publication of DE2946275A1 publication Critical patent/DE2946275A1/de
Application granted granted Critical
Publication of DE2946275C2 publication Critical patent/DE2946275C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19792946275 1979-11-16 1979-11-16 Verbessertes verfahren zur herstellung von humaninterferon aus lymphoblastoiden zellen Granted DE2946275A1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE19792946275 DE2946275A1 (de) 1979-11-16 1979-11-16 Verbessertes verfahren zur herstellung von humaninterferon aus lymphoblastoiden zellen
AT0506880A AT374828B (de) 1979-11-16 1980-10-13 Verfahren zur herstellung von humaninterferon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792946275 DE2946275A1 (de) 1979-11-16 1979-11-16 Verbessertes verfahren zur herstellung von humaninterferon aus lymphoblastoiden zellen

Publications (2)

Publication Number Publication Date
DE2946275A1 DE2946275A1 (de) 1981-05-27
DE2946275C2 true DE2946275C2 (enExample) 1987-11-05

Family

ID=6086143

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19792946275 Granted DE2946275A1 (de) 1979-11-16 1979-11-16 Verbessertes verfahren zur herstellung von humaninterferon aus lymphoblastoiden zellen

Country Status (2)

Country Link
AT (1) AT374828B (enExample)
DE (1) DE2946275A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3016255A1 (de) * 1980-04-26 1981-10-29 Messerschmitt-Bölkow-Blohm GmbH, 8000 München Gasgefuellter fahrzeugreifen
DE3930140A1 (de) * 1989-09-09 1991-03-21 Bayer Ag Verfahren zur herstellung von biologischen materialien in zellkulturen und vorrichtungen
WO2021058811A1 (en) * 2019-09-25 2021-04-01 Philipps-Universität Marburg Short-chain fatty acid pentanoate as enhancer for cellular therapy and anti-tumor therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS215108B2 (en) * 1977-07-15 1982-07-30 Wellcome Found Method of making the interferrone

Also Published As

Publication number Publication date
AT374828B (de) 1984-06-12
ATA506880A (de) 1983-10-15
DE2946275A1 (de) 1981-05-27

Similar Documents

Publication Publication Date Title
DE3853535T2 (de) Ärztliche antimikrobielle polypeptide, deren verwendung und verfahren zur herstellung.
DE3689246T2 (de) Physiologisch aktives Polypeptid BUF-3.
EP0005476B1 (de) Verfahren zur Herstellung von Humaninterferon
DE3704389C2 (enExample)
DE69329841T2 (de) Verfahren zur Unterdrückung der Koloration von menschlichem Serum-Albumin
DE2946275C2 (enExample)
CH628246A5 (de) Verfahren zur herstellung eines schuetzenden pertussis-antigens.
EP0367840B1 (de) Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie
CH651317A5 (de) Verfahren zur enzymatischen synthese von doppelstrangiger rna, nach diesem verfahren synthetisierte doppelstrangige rna und diese enthaltende interferon-induktoren.
EP0062085B1 (de) Verbessertes Verfahren zur Herstellung von Humaninterferon aus lymphoblastoiden Zellen
DE3434122C2 (enExample)
DE3325131C2 (enExample)
DE2821466A1 (de) Verbessertes verfahren zur herstellung von humaninterferon
DE3249215C2 (de) Verfahren zur herstellung von humanem gamma-interferon.
DE69107815T2 (de) Verfahren zur Herstellung neuer nichtkovalenten Polysaccharid-Protein-Zusammensetzungen mit pharmakologischen Eigenschaften.
EP0203382A2 (de) Verfahren zur Herstellung und Reinigung von alpha-Interferon
DE68928138T2 (de) Neuer megakaryokytischer koloniestimulierender faktor und verfahren zur herstellung
CH646875A5 (de) Verfahren zur gewinnung eines interferons und interferon hergestellt nach diesem verfahren.
DE69710349T2 (de) 1,3-dicarbonsäuregermaniumkomplex und dessen therapeutische verwendung
DE69022606T2 (de) Menschlichen Monozyt-Makrophagen-Koloniestimulierungsfaktor enthaltende Zusammensetzung.
DE2724918A1 (de) Gewinnung und reinigung von humaninterferon
DE3019621C2 (de) Verfahren zur Herstellung von Interferon II.
EP0083734B1 (de) Kristallines Human-Leukocyten-Interferon
DE2906160A1 (de) Verbessertes verfahren zur herstellung von humaninterferon
EP0135797A2 (de) Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee